Skip to main content

Table 1 Characteristics of the study patients

From: Levosimendan for resuscitating the microcirculation in patients with septic shock: a randomized controlled study

  Levosimendan (n = 20) Control (n = 20) P value
Age, years 68 (55; 74) 66 (54; 78) 0.98
Gender, male 70% 65% 1.00
SAPS II 55 (45; 61) 57 (46; 64) 0.90
Cause of septic shock Endocarditis (n = 1)
Peritonitis (n = 8)
Pneumonia (n = 11)
Peritonitis (n = 4)
Pneumonia (n = 16)
0.10
Onset of septic shock, hoursa 20 (18; 24) 18 (13; 22) 0.13
ICU mortality 13/20 15/20 0.50
ICU length of stay, days 14 (11; 19) 27 (9; 47) 0.32
  1. Data are presented as median (25th; 75th percentile). Control, dobutamine 5 μg/kg per minute. aOnset of septic shock defines the time elapsed from the onset of septic shock until administration of study drug. ICU, intensive care unit; SAPS II, Simplified Acute Physiology Score II.
\